average length criterion;
average posterior variance criteria;
average coverage criterion;
equivalence test;
non-inferiority test;
sample size determination;
MCNEMARS TEST;
PROPORTIONS;
DIFFERENCE;
DESIGN;
STANDARD;
D O I:
10.1080/02664760903150714
中图分类号:
O21 [概率论与数理统计];
C8 [统计学];
学科分类号:
020208 ;
070103 ;
0714 ;
摘要:
Bayesian sample size estimation for equivalence and non-inferiority tests for diagnostic methods is considered. The goal of the study is to test whether a new screening test of interest is equivalent to, or not inferior to the reference test, which may or may not be a gold standard. Sample sizes are chosen by the model performance criteria of average posterior variance, length and coverage probability. In the absence of a gold standard, sample sizes are evaluated by the ratio of marginal probabilities of the two screening tests; whereas in the presence of gold standard, sample sizes are evaluated by the measures of sensitivity and specificity.
机构:
Univ Shizuoka, Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka, JapanUniv Shizuoka, Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka, Japan
Kawasaki, Yohei
Doi, Masaaki
论文数: 0引用数: 0
h-index: 0
机构:
Toray Industries Ltd, Clin Data Sci & Qual Management Dept, Tokyo, Japan
Chuo Univ, Sch Sci & Engn, Tokyo, JapanUniv Shizuoka, Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka, Japan
Doi, Masaaki
Ide, Kazuki
论文数: 0引用数: 0
h-index: 0
机构:
Univ Shizuoka, Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka, JapanUniv Shizuoka, Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka, Japan
Ide, Kazuki
Miyaoka, Etsuo
论文数: 0引用数: 0
h-index: 0
机构:
Tokyo Univ Sci, Dept Math, Tokyo, JapanUniv Shizuoka, Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka, Japan